[HTML][HTML] Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization
DW Schmidt, DB Maier, JC Nulsen, CA Benadiva - Fertility and Sterility, 2004 - Elsevier
OBJECTIVE: The lowest effective hCG dose in high responders during IVF–embryo transfer
(ET) has not been established. This study was performed to confirm that a dose of 3,300 IU …
(ET) has not been established. This study was performed to confirm that a dose of 3,300 IU …
[HTML][HTML] Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in …
BS Shapiro, ST Daneshmand, FC Garner, M Aguirre… - Fertility and sterility, 2005 - Elsevier
OBJECTIVE: To determine whether the serum concentration of hCG on the day after hCG
administration (abbreviated throughout this article as [hCG]) is related to the incidence of …
administration (abbreviated throughout this article as [hCG]) is related to the incidence of …
[HTML][HTML] Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk …
LL Engmann, BS Maslow, LA Kaye, DW Griffin… - Journal of Ovarian …, 2019 - Springer
Background Ovarian hyperstimulation syndrome remains a serious complication during in
vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger …
vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger …
Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
J Haas, E Zilberberg, R Machtinger… - Gynecological …, 2015 - Taylor & Francis
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …
Ovarian hyperstimulation syndrome prevention strategies: reducing the human chorionic gonadotropin trigger dose
S Kashyap, K Parker, MI Cedars… - Seminars in …, 2010 - thieme-connect.com
This article reviews the biological plausibility and evidence for the use of a low triggering
dose of human chorionic gonadotropin (hCG) in the prevention of ovarian hyperstimulation …
dose of human chorionic gonadotropin (hCG) in the prevention of ovarian hyperstimulation …
Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment
Objective Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic condition,
predominantly related to the hormone used to induce oocyte maturation during IVF …
predominantly related to the hormone used to induce oocyte maturation during IVF …
[HTML][HTML] Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in …
D Griffin, C Benadiva, N Kummer, T Budinetz… - Fertility and sterility, 2012 - Elsevier
OBJECTIVE: To compare live birth rates after dual trigger of oocyte maturation with GnRH
agonist (GnRHa) and low-dose hCG versus GnRHa alone in high responders with peak E2< …
agonist (GnRHa) and low-dose hCG versus GnRHa alone in high responders with peak E2< …
[HTML][HTML] Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome
CA Benadiva, O Davis, I Kligman, M Moomjy, HC Liu… - Fertility and …, 1997 - Elsevier
Objective: To evaluate the outcomes of IVF and the incidence of ovarian hyperstimulation
syndrome (OHSS) after discontinuing gonadotropin therapy in patients at risk of developing …
syndrome (OHSS) after discontinuing gonadotropin therapy in patients at risk of developing …
GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone
KE O'Neill, S Senapati, I Maina, C Gracia… - Journal of assisted …, 2016 - Springer
Purpose The purpose of this study was to compare rates of ovarian hyperstimulation
syndrome (OHSS) after using gonadotropin-releasing hormone agonists (GnRHa) alone …
syndrome (OHSS) after using gonadotropin-releasing hormone agonists (GnRHa) alone …
Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation
AB Copperman, GM Horowitz, P Kaplan, RT Scott… - Fertility and sterility, 1995 - Elsevier
Objective To determine if premature luteinization (serum P levels> 1.1 ng/mL on or before
the day of hCG administration) during controlled ovarian hyperstimulation (COH) is …
the day of hCG administration) during controlled ovarian hyperstimulation (COH) is …